Amicus Therapeutics, Inc. (FOLD): Price and Financial Metrics

FOLD POWR Grades

• Quality is the dimension where FOLD ranks best; there it ranks ahead of 85.36% of US stocks.
• FOLD's strongest trending metric is Momentum; it's been moving up over the last 179 days.
• FOLD's current lowest rank is in the Momentum metric (where it is better than 23.68% of US stocks).

FOLD Stock Summary

• The capital turnover (annual revenue relative to shareholder's equity) for FOLD is 2.44 -- better than 78.03% of US stocks.
• Of note is the ratio of AMICUS THERAPEUTICS INC's sales and general administrative expense to its total operating expenses; just 20.3% of US stocks have a lower such ratio.
• With a price/sales ratio of 10.14, AMICUS THERAPEUTICS INC has a higher such ratio than 88.97% of stocks in our set.
• Stocks that are quantitatively similar to FOLD, based on their financial statements, market capitalization, and price volatility, are APLS, MIRM, GWH, SAGE, and ABSI.
• Visit FOLD's SEC page to see the company's official filings. To visit the company's web site, go to www.amicusrx.com.

FOLD Valuation Summary

• FOLD's price/sales ratio is 9; this is 373.68% higher than that of the median Healthcare stock.
• Over the past 188 months, FOLD's EV/EBIT ratio has gone down 6.2.

Below are key valuation metrics over time for FOLD.

FOLD Growth Metrics

Its 5 year net income to common stockholders growth rate is now at -62.48%.
• The year over year revenue growth rate now stands at 19.14%.
• Its 4 year cash and equivalents growth rate is now at -34.11%.

Over the past 30 months, FOLD's revenue has gone up $138,908,000.

The table below shows FOLD's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-06-30	321.145	-168.391	-280.988
2022-03-31	317.827	-188.452	-270.056
2021-12-31	305.514	-202.491	-250.46
2021-09-30	293.931	-181.799	-238.584
2021-06-30	281.823	-200.107	-252.301
2021-03-31	266.763	-197.702	-253.568

FOLD's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• FOLD has a Quality Grade of C, ranking ahead of 63.39% of graded US stocks.
• FOLD's asset turnover comes in at 0.333 -- ranking 138th of 680 Pharmaceutical Products stocks.
• RDUS, CLVS, and NSTG are the stocks whose asset turnover ratios are most correlated with FOLD.

The table below shows FOLD's key quality metrics over time.